132 related articles for article (PubMed ID: 30499617)
1. Clonality and heterogeneity of metachronous colorectal cancer.
Di J; Yang H; Wang Z; Yang J; Gao P; Jiang B; Su X
Mol Carcinog; 2019 Mar; 58(3):447-457. PubMed ID: 30499617
[TBL] [Abstract][Full Text] [Related]
2. Whole exome sequencing reveals intertumor heterogeneity and distinct genetic origins of sporadic synchronous colorectal cancer.
Di J; Yang H; Jiang B; Wang Z; Ji J; Su X
Int J Cancer; 2018 Mar; 142(5):927-939. PubMed ID: 29105743
[TBL] [Abstract][Full Text] [Related]
3. Tumor Seeding During Colonoscopy as a Possible Cause for Metachronous Colorectal Cancer.
Backes Y; Seerden TCJ; van Gestel RSFE; Kranenburg O; Ubink I; Schiffelers RM; van Straten D; van der Capellen MS; van de Weerd S; de Leng WWJ; Siersema PD; Offerhaus GJA; Morsink FH; Ramphal W; Terhaar Sive Droste J; van Lent AUG; Geesing JMJ; Vleggaar FP; Elias SG; Lacle MM; Moons LMG
Gastroenterology; 2019 Nov; 157(5):1222-1232.e4. PubMed ID: 31419435
[TBL] [Abstract][Full Text] [Related]
4. Discovery of Aberrant Alteration of Genome in Colorectal Cancer by Exome Sequencing.
Liang Y; Jiang L; Zhong X; Hochwald SN; Wang Y; Huang L; Nie Q; Huang H; Xu JF
Am J Med Sci; 2019 Nov; 358(5):340-349. PubMed ID: 31445671
[TBL] [Abstract][Full Text] [Related]
5. Whole Exome Sequencing of Ulcerative Colitis-associated Colorectal Cancer Based on Novel Somatic Mutations Identified in Chinese Patients.
Yan P; Wang Y; Meng X; Yang H; Liu Z; Qian J; Zhou W; Li J
Inflamm Bowel Dis; 2019 Jul; 25(8):1293-1301. PubMed ID: 30794281
[TBL] [Abstract][Full Text] [Related]
6. New genetic variations discovered in KRAS wild-type cetuximab resistant chinese colorectal cancer patients.
Jing C; Wang T; Ma R; Cao H; Wang Z; Liu S; Chen D; Zhang J; Wu Y; Zhang Y; Wu J; Feng J
Mol Carcinog; 2020 May; 59(5):478-491. PubMed ID: 32141150
[TBL] [Abstract][Full Text] [Related]
7. Altered DNA mismatch repair expression in synchronous and metachronous colorectal cancers.
Aslanian HR; Burgart LJ; Harrington JJ; Mahoney DW; Zinsmeister AR; Thibodeau SN; Ahlquist DA
Clin Gastroenterol Hepatol; 2008 Dec; 6(12):1385-8. PubMed ID: 18639494
[TBL] [Abstract][Full Text] [Related]
8. Influence of KRAS mutation status in metachronous and synchronous metastatic colorectal adenocarcinoma.
Rose JS; Serna DS; Martin LK; Li X; Weatherby LM; Abdel-Misih S; Zhao W; Bekaii-Saab T
Cancer; 2012 Dec; 118(24):6243-52. PubMed ID: 22674181
[TBL] [Abstract][Full Text] [Related]
9. Characterization of genetic intratumor heterogeneity in colorectal cancer and matching patient-derived spheroid cultures.
Árnadóttir SS; Jeppesen M; Lamy P; Bramsen JB; Nordentoft I; Knudsen M; Vang S; Madsen MR; Thastrup O; Thastrup J; L Andersen C
Mol Oncol; 2018 Jan; 12(1):132-147. PubMed ID: 29130628
[TBL] [Abstract][Full Text] [Related]
10. Synchronous and Metachronous Colorectal Cancers: Distinct Disease Entities or Different Disease Courses?
Huang CS; Yang SH; Lin CC; Lan YT; Chang SC; Wang HS; Chen WS; Lin TC; Lin JK; Jiang JK
Hepatogastroenterology; 2015 Jun; 62(140):838-42. PubMed ID: 26902012
[TBL] [Abstract][Full Text] [Related]
11. Association between family history of colorectal cancer and the risk of metachronous colorectal neoplasia following polypectomy in patients aged < 50 years.
Kim NH; Jung YS; Park JH; Park DI; Sohn CI
J Gastroenterol Hepatol; 2019 Feb; 34(2):383-389. PubMed ID: 30554426
[TBL] [Abstract][Full Text] [Related]
12. Tumor size is an independent risk predictor for metachronous colorectal cancer.
Kato T; Alonso S; Muto Y; Perucho M; Rikiyama T
Oncotarget; 2016 Apr; 7(14):17896-904. PubMed ID: 26910116
[TBL] [Abstract][Full Text] [Related]
13. Comparative sequence analysis of patient-matched primary colorectal cancer, metastatic, and recurrent metastatic tumors after adjuvant FOLFOX chemotherapy.
Harada K; Okamoto W; Mimaki S; Kawamoto Y; Bando H; Yamashita R; Yuki S; Yoshino T; Komatsu Y; Ohtsu A; Sakamoto N; Tsuchihara K
BMC Cancer; 2019 Mar; 19(1):255. PubMed ID: 30898102
[TBL] [Abstract][Full Text] [Related]
14. Quantification of multicellular colonization in tumor metastasis using exome-sequencing data.
Nishino J; Watanabe S; Miya F; Kamatani T; Sugawara T; Boroevich KA; Tsunoda T
Int J Cancer; 2020 May; 146(9):2488-2497. PubMed ID: 32020592
[TBL] [Abstract][Full Text] [Related]
15. Synchronous and metachronous colorectal cancers: distinct disease entities or different disease courses?
Huang CS; Yang SH; Lin CC; Lan YT; Chang SC; Wang HS; Chen WS; Lin TC; Lin JK; Jiang JK
Hepatogastroenterology; 2015; 62(138):286-90. PubMed ID: 25916050
[TBL] [Abstract][Full Text] [Related]
16. Tumor Heterogeneity Predicts Metastatic Potential in Colorectal Cancer.
Joung JG; Oh BY; Hong HK; Al-Khalidi H; Al-Alem F; Lee HO; Bae JS; Kim J; Cha HU; Alotaibi M; Cho YB; Hassanain M; Park WY; Lee WY
Clin Cancer Res; 2017 Dec; 23(23):7209-7216. PubMed ID: 28939741
[No Abstract] [Full Text] [Related]
17. Is MSI-H of value in predicting the development of metachronous colorectal cancer?
Lawes DA; Pearson T; Sengupta S; Boulos PB
Eur J Cancer; 2006 Mar; 42(4):473-6. PubMed ID: 16427780
[TBL] [Abstract][Full Text] [Related]
18. Multiregion whole-exome sequencing of matched primary and metastatic tumors revealed genomic heterogeneity and suggested polyclonal seeding in colorectal cancer metastasis.
Wei Q; Ye Z; Zhong X; Li L; Wang C; Myers RE; Palazzo JP; Fortuna D; Yan A; Waldman SA; Chen X; Posey JA; Basu-Mallick A; Jiang BH; Hou L; Shu J; Sun Y; Xing J; Li B; Yang H
Ann Oncol; 2017 Sep; 28(9):2135-2141. PubMed ID: 28911083
[TBL] [Abstract][Full Text] [Related]
19. The prognostic values of EGFR expression and KRAS mutation in patients with synchronous or metachronous metastatic colorectal cancer.
Huang CW; Tsai HL; Chen YT; Huang CM; Ma CJ; Lu CY; Kuo CH; Wu DC; Chai CY; Wang JY
BMC Cancer; 2013 Dec; 13():599. PubMed ID: 24330663
[TBL] [Abstract][Full Text] [Related]
20. Major driver mutations are shared between sinonasal intestinal-type adenocarcinoma and the morphologically identical colorectal adenocarcinoma.
Sjöstedt S; Schmidt AY; Vieira FG; Willemoe GL; Agander TK; Olsen C; Nielsen FC; von Buchwald C
J Cancer Res Clin Oncol; 2021 Apr; 147(4):1019-1027. PubMed ID: 33051725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
